Threadline News
SearchGet the morning brief

Form 8-K, current report

Actinium Pharmaceuticals, Inc., 8-K filed 2026-08-14

Published 14 Aug 2026 · retrieved 16 Aug 2026, 02:30 EDT · version 1Official source

The full text was pulled automatically from the official source and is not Threadline News reporting; the annotations alongside it are.

Filing record

1

8-K filed with the Securities and Exchange Commission by Actinium Pharmaceuticals, Inc. (CIK 0001388320) on 2026-08-14.

2

Accession number 0001213900-26-090232. EDGAR reports the filing package as 259 KB. The filing index, including every exhibit, is at https://www.sec.gov/Archives/edgar/data/1388320/000121390026090232/0001213900-26-090232-index.htm.

Items reported on the cover

1

Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

2

Item 7.01: Regulation FD Disclosure

3

Item 9.01: Financial Statements and Exhibits